MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Aktis Oncology, Inc. Common stock

AKTS

#7638
Aktis Oncology, Inc. Common stock
20.13
+4.95%
Sector:
Básica:
Profit Currency:
Rango diario
20.13
20.13
Rango anual
16.80
29.16
Cambio diario
+4.95%
Monthly Change
-2.66%
6 month change
-25.44%
Cambio anual
-25.44%
Cierres anteriores
19.18
Open
20.13
Bid
Ask
Low
20.13
High
20.13
Volumen
12
  1. Markets
  2. Acciones
  3. Tecnología
  4. AKTS
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
No hay datos

Noticias

Investing Investing
AKTS
2026.02.03
BofA Securities startet Coverage für Akoustis Technologies mit Kaufempfehlung
Investing Investing
AKTS
2026.02.03
BofA Securities initiates coverage on Akoustis Technologies stock with Buy rating
Investing Investing
AKTS
2026.02.03
TD Cowen startet Coverage für Akoustis Technologies mit Kaufempfehlung
Investing Investing
AKTS
2026.02.03
Cowen initiates Akoustis Technologies stock with Buy rating
Investing Investing
AKTS
2026.02.03
JPMorgan startet Coverage für Aktis Oncology mit "Overweight"-Rating
Investing Investing
AKTS
2026.02.03
Akoustis Technologies stock initiated with Overweight rating by JPMorgan
Investing Investing
MKC-V IPGP WRB-PF ROKU AKTS
2026.01.15
Wednesday Insider Activity: Mitsui’s $55.6M Berkley Buy Leads the Pack
Investing Investing
AKTS
2026.01.14
Insider-Kauf bei Aktis Oncology: Direktor Foley investiert 4,19 Millionen US-Dollar
Investing Investing
AKTS
2026.01.14
Aktis Oncology director Foley buys $4.19 million in shares
Investing Investing
AKTS
2026.01.14
Aktis Oncology: MPM Funds kauft Aktien im Wert von 20 Mio. US-Dollar
Investing Investing
AKTS
2026.01.14
Aktis Oncology: Mpm funds buy shares worth $20m
Investing Investing
AKTS
2026.01.14
Aktis Oncology (AKTS) sees $20 million purchase by 10% owner

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd